Serum levels of fibrosis biomarkers measured early after liver transplantation are associated with severe hepatitis C virus recurrence: Short communication

Transplant Infectious Disease

Volumn 11, Issue 2, 2009, Pages 183-188

  Micheloud, D ^a   Salcedo, M ^b,c   Banares R ^b,c   Rincon D ^b,c   Lorente, R ^b   Munoz Fernandez M A ^b   Resino, Salvador ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Angiogenesis; Biomarkers; Chemokines; Cytokines; Endothelial adhesion; Fibrosis; Hepatitis C; Liver transplantation; Predictive serum markers

Indexed keywords

BASILIXIMAB; BIOLOGICAL MARKER; CORTICOSTEROID; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYALURONIC ACID; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID; TACROLIMUS; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER FIBROSIS; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT INFECTION;

ADULT; AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL2; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HEPATITIS C; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; LIVER DISEASES, ALCOHOLIC; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECURRENCE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 64249096591     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00370.x     Document Type: Article

References (12)

1. Bialek SR, Terrault NA. The changing epidemiology and natural history of hepatitis C virus infection. Clin Liver Dis 2006 10 (4) : 697 715.
2. Garcia-Retortillo M, Forns X, Feliu A, et al. Hepatitis C virus kinetics during and immediately after liver transplantation. Hepatology 2002 35 (3) : 680 687.
3. Chan SE, Rosen HR. Outcome and management of hepatitis C in liver transplant recipients. Clin Infect Dis 2003 37 (6) : 807 812.
4. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000 32 (4) : 673 684.
5. Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004 99 (6) : 1160 1174.
6. Rayhill SC, Wu YM, Katz DA, et al. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation 2007 84 (3) : 331 339.
7. Meneghin A, Hogaboam CM. Infectious disease, the innate immune response, and fibrosis. J Clin Invest 2007 117 (3) : 530 538.
8. Apolinario A, Majano PL, Lorente R, Nunez O, Clemente G, Garcia-Monzon C. Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins. J Viral Hepat 2005 12 (1) : 27 37.
9. Apolinario A, Majano PL, Alvarez-Perez E, et al. Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease. Am J Gastroenterol 2002 97 (11) : 2861 2870.
10. Bruno CM, Sciacca C, Cilio D, et al. Circulating adhesion molecules in patients with virus-related chronic diseases of the liver. World J Gastroenterol 2005 11 (29) : 4566 4569.
11. Salcedo X, Medina J, Sanz-Cameno P, et al. The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology 2005 42 (3) : 696 701.
12. Akiyoshi F, Sata M, Suzuki H, et al. Serum vascular endothelial growth factor levels in various liver diseases. Dig Dis Sci 1998 43 (1) : 41 45.